Inventor · disambiguated record
Peter Ronald Young
Also filed as: YOUNG PETER · YOUNG PETER R · YOUNG PETER RONALD
46 granted patents·18 pending applications·1,298 citations·filing 1994–2024
99Inventor score
Files withSMITHKLINE BEECHAM CORP26ZENITH EPIGENETICS LTD10AI THERAPEUTICS INC5MCLURE KEVIN G4ZENITH EPIGENETICS CORP3
Top patents by PatentIndex Score
64 records- 0196US9765039B2Biaryl derivatives as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2013·Granted Sep 19, 2017·27 cites·4 claims
- 0295US11957688B2Combination therapy with apilimod and glutamatergic agentsAI THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·2 cites·21 claims
- 0395US11439649B2Combination therapy with apilimod and glutamatergic agentsAI THERAPEUTICS INC·Filed 2020·Granted Sep 13, 2022·4 cites·21 claims
- 0494US9861637B2Heterocyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2017·Granted Jan 9, 2018·20 cites·19 claims
- 0594US9662311B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2014·Granted May 30, 2017·25 cites·6 claims
- 0694US9271978B2Heterocyclic compounds as bromodomain inhibitorsLIU SHUANG·Filed 2013·Granted Mar 1, 2016·30 cites·13 claims
- 0793US9663520B2Bicyclic bromodomain inhibitorsZENITH EPIGENETICS CORP·Filed 2015·Granted May 30, 2017·16 cites·25 claims
- 0893US9278940B2Cyclic amines as bromodomain inhibitorsFAIRFAX DAVID JOHN·Filed 2015·Granted Mar 8, 2016·25 cites·31 claims
- 0993US6998124B1Erythropoietin receptor antibodiesSMITHKLINE BEECHAM CORP·Filed 2000·Granted Feb 14, 2006·39 cites·16 claims
- 1093US5783181ATherapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists and immunoglobulinsSMITHKLINE BEECHAM CORP·Filed 1995·Granted Jul 21, 1998·152 cites·9 claims
- 1192US9636328B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS CORP·Filed 2014·Granted May 2, 2017·19 cites·6 claims
- 1292US9598367B2Heterocyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS CORP·Filed 2016·Granted Mar 21, 2017·15 cites·4 claims
- 1392US5871934AScreening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteinsSMITHKLINE BEECHAM CORP·Filed 1994·Granted Feb 16, 1999·96 cites·7 claims
- 1492US5777097AOligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding proteinSMITHKLINE BEECHAM CORP·Filed 1995·Granted Jul 7, 1998·96 cites·1 claims
- 1591US9073878B2Cyclic amines as bromodomain inhibitorsFAIRFAX DAVID JOHN·Filed 2013·Granted Jul 7, 2015·20 cites·19 claims
- 1691US6313269B1Tumor necrosis factor related receptor, TR6SMITHKLINE BEECHAM CORP·Filed 1999·Granted Nov 6, 2001·120 cites·2 claims
- 1790US6153190AErythropoietin receptor antibodiesFiled 1996·Granted Nov 28, 2000·80 cites·2 claims
- 1890US5869043ADrug binding proteinSMITHKLINE BEECHAM CORP·Filed 1996·Granted Feb 9, 1999·86 cites·2 claims
- 1989US10751345B2Combination therapy with apilimod and glutamatergic agentsAI THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·5 cites·30 claims
- 2087US5955366APolynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteinsSMITHKLINE BEECHAM CORP·Filed 1997·Granted Sep 21, 1999·46 cites·25 claims
- 2186US10010556B2Bicyclic bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2017·Granted Jul 3, 2018·4 cites·54 claims
- 2286US5783664ACytokine suppressive anit-inflammatory drug binding proteinsSMITHKLINE BEECHAM CORP·Filed 1994·Granted Jul 21, 1998·86 cites·6 claims
- 2380US10226451B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2017·Granted Mar 12, 2019·2 cites·5 claims
- 2477US6399573B1Interleukin-1 receptor antagonist beta (IL-1rabeta)SMITHKLINE BEECHAM CORP·Filed 2000·Granted Jun 4, 2002·8 cites·1 claims
- 2576US10166215B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2017·Granted Jan 1, 2019·1 cites·14 claims
- 2675US5863769ADNA encoding interleukin-1 receptor antagonist (IL-1raβ)SMITHKLINE BEECHAM CORP·Filed 1997·Granted Jan 26, 1999·40 cites·19 claims
- 2773US6297359B1Protein phosphatase 1 binding protein, R5SMITHKLINE BEECHAM CORP·Filed 2000·Granted Oct 2, 2001·4 cites·4 claims
- 2872US11446306B2Bicyclic bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2020·Granted Sep 20, 2022·0 cites·22 claims
- 2971US7049422B2Tumor necrosis related receptor, TR7SMITHKLINE BEECHAM CORP·Filed 2003·Granted May 23, 2006·5 cites·17 claims
- 3071US6033873ADrug binding proteinSMITHKLINE BEECHAM CORP·Filed 1998·Granted Mar 7, 2000·29 cites·11 claims
- 3170US6297022B1Method of identifying agonists and antagonists for tumor necrosis related receptor TR1SMITHKLINE BEECHAM CORP·Filed 1998·Granted Oct 2, 2001·28 cites·10 claims
- 3269US6342371B1Interleukin-1 homologue, IL-1H4SMITHKLINE BEECHAM CORP·Filed 1999·Granted Jan 29, 2002·17 cites·11 claims
- 3368US5885800ADNA encoding tumor necrosis related receptor, TR4SMITHKLINE BEECHAM CORP·Filed 1997·Granted Mar 23, 1999·30 cites·16 claims
- 3466US10772892B2Bicyclic bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2019·Granted Sep 15, 2020·0 cites·15 claims
- 3566US2024277720A1Stabilized apilimod compositions and uses thereofORPHAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3665US11026926B2Substituted bicyclic compounds as bromodomain inhibitorsZENITH EPIGENETICS LTD·Filed 2019·Granted Jun 8, 2021·0 cites·7 claims
- 3765US6013476ADNA encoding tumor necrosis related receptor TR7SMITHKLINE BEECHAM CORP·Filed 1997·Granted Jan 11, 2000·21 cites·18 claims
- 3863US6054559AInterleukin-1 receptor antagonist beta (IL-1raβ)SMITHKLINE BEECHAM CORP·Filed 1998·Granted Apr 25, 2000·14 cites·4 claims
- 3961US6361773B1Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteinsSMITHKLINE BEECHAM CORP·Filed 1997·Granted Mar 26, 2002·21 cites·4 claims
- 4059US6218136B1Methods of the identification of pharmaceutically active compoundsSMITHKLINE BEECHAM CORP·Filed 1997·Granted Apr 17, 2001·16 cites·16 claims
- 4158US2019091229A1Therapeutic methods relating to hsp90 inhibitorsLAM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4258US2024374523A1Stabilized apilimod compositions and uses thereofORPHAI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4357US5945310ADNA encoding members of the IL-1 family, IL-1 deltaSMITHKLINE BEECHAM CORP·Filed 1997·Granted Aug 31, 1999·20 cites·11 claims
- 4457US2020253979A1Therapeutic methods relating to hsp90 inhibitorsAI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4554US6660839B1Tumor necrosis related receptor, TR7SMITHKLINE BEECHAM CORP·Filed 1999·Granted Dec 9, 2003·9 cites·17 claims
- 4652US2024189317A1Antiviral compositions and methodsAI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4751US2003064481A1Novel compoundsSMITHKLINE BEECHAM CORP AND SM·Filed 2002·Application pending·0 cites
- 4850US2004106135A1Assay for PPAR ligand dependent gene modulationFiled 2003·Application pending·0 cites
- 4950US2021077500A1Pikfyve inhibitors for cancer therapyAL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5048US2021244743A1Anti-viral compositions and methods of useAL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Ronald Young files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →